The Latest Breaking News from MDT

Edwards Lifesciences has recently underperformed the broader S&P 500, yet analysts remain moderately optimistic about the stock's potential.

Although Medtronic has lagged behind the broader S&P 500 index over the past three months, analysts remain moderately optimistic about the stock’s prospects.

Medtronic's stock price is in a classic head-and-shoulders reversal that could take it back to record highs within the next two years.

Disgraced surgeon Ian Paterson said it was ‘nonsense’ that an open breast biopsy and double mastectomy performed on a patient were unnecessary.

December S&P 500 E-Mini futures (ESZ24) are down -0.40%, and December Nasdaq 100 E-Mini futures (NQZ24) are down -0.32% this morning as risk sentiment took a hit after Russian President Vladimir Putin updated the country’s nuclear doctrine, while investors awaited fresh data on the U.S. housing market and an earnings…

An inquest at Birmingham and Solihull Coroners Court concluded Christine Gould received appropriate care but died of natural causes.

The rapidly growing aging population is driving expansion in healthcare, with rising demand for treatments and chronic disease management. Companies like AbbVie (ABBV), Medtronic (MDT), and Centene (CNC) are well-positioned to meet these needs, making them attractive options for investors seeking to capitalize on the industry’s sustained growth potential. Read…

Medtronic has lagged behind the broader market over the past year, and analysts remain cautiously bullish on the stock’s prospects.

Schoolteacher Christine Baker and her husband were not made aware that reconstructive surgery carried a higher risk, an inquest was told.

Ian Paterson gave evidence at the inquest into the death of former patient Elaine Turbill from prison on Thursday.

Medtronic will release its second-quarter earnings next month, and analysts anticipate a slight profit dip.